anti-Nipah browse page allows user to take a glance of the particular anti-Nipah ihibitor.By clicking on the table header arrows, user can sort entries in ascending or descending order.Moreover, the user can get the detal of every inhibitor by clicking on individual ID.


Total number of Records for NiV-pVSV are 37




anti-Nipah_ID Drug Name
Nipah virus strain
Assay
Activity Type
Activity
References
anti-Nipah_277(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_278(5Z)-3-Ethyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_279(5Z)-5-[(5-Phenyl-2-furyl)methylene]-3-propyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_280(5Z)-3-Benzyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_281(5Z)-3-Methyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_282(5Z)-5-{[5-(3-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_283(5Z)-3-Ethyl-5-{[5-(3-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2843-Ethyl-5-{[5-(2-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_285(5Z)-5-{[5-(2-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_286(5Z)-3-ethyl-5-{[5-(2-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_287(5Z)-3-ethyl-5-{[5-(3-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_288(5Z)-3-Ethyl-2-thioxo-5-({5-[2-(trifluoromethyl)phenyl]-2-furyl}methylene)-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_289(5Z)-3-Ethyl-5-[(5-methyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_290(5Z)-3-Ethyl-5-(2-furylmethylene)-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_291(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_292(5Z)-3-ethyl-5-{[5-(2-hydroxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_293(5Z)-5-{[5-(2-aminophenyl)furan-2-yl]methylidene}-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_294(5Z)-3-ethyl-5-[(5-phenylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_295(5Z)-5-({[1,1-biphenyl]-3-yl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2962-(5-{[(5Z)-3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-diazonium; tetrafluoroboranuide
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2973-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl acetate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_298(5Z)-3-(3-hydroxypropyl)-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_299(5Z)-3-ethyl-5-[(2-phenyl-1,3-oxazol-5-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_300 3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_301(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-3-vinyl-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_302(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazolidine-2,4-dione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_303(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dithione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_304(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-1,3-thiazolidine-2,4-dithione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_305(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-4-sulfanylidene-1,3-thiazolidin-2-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_306(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-4-sulfanylidene-1,3-thiazolidin-2-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_307(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_308(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-(prop-2-yn-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3095-[(5-phenylfuran-2-yl)methyl]-3-(prop-2-en-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_310N-{3-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl}acetamide
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_311(5Z)-3-(3-aminopropyl)-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3122-methylpropyl N-{3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl}carbamate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3133-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A